Tag - XAIR

Markets

BTIG starts Beyond Air at buy; PT $15

BTIG initiated coverage of Beyond Air (NASDAQ:XAIR) with a “buy” rating and $15 price target. The stock closed at $5.73 on June 14. Beyond Air is a medical device company that has developed a technology to turn room air...

June 15, 2023

Feature

Beyond Air’s cylinder-free nitric oxide delivery system for respiratory conditions

Beyond Air (NASDAQ:XAIR), formerly AIT Therapeutics, is developing a proprietary nitric oxide (NO) generator and delivery system that uses NO generated from ambient air, rather than bulky cylinders, and delivers precise...

August 20, 2019

Tag - XAIR

BTIG starts Beyond Air at buy; PT $15

Beyond Air’s cylinder-free nitric oxide delivery system for respiratory conditions

General

More